A Novel Anti-Egfr mAb Ame55 With Lower Toxicity and Better Efficacy Than Cetuximab When Combined With Irinotecan

Journal of Immunology Research - Egypt
doi 10.1155/2019/3017360
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Erlotinib Has Better Efficacy Than Gefitinib in Adenocarcinoma Patients Without EGFR-activating Mutations, but Similar Efficacy in Patients With EGFR-activating Mutations

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2011English

Assessment of 213Bi-Anti-Egfr MAb Treatment Efficacy in Malignant Cancer Cells With [1-13C]pyruvate and [18F]FDG

Scientific Reports
Multidisciplinary
2019English

GC1118, a Novel Anti-Egfr Antibody, Has Potent KRAS Mutation-Independent Antitumor Activity Compared With Cetuximab in Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2019English

Significant Therapeutic Efficacy With Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Concomitant and Feasible Treatment With Dasatinib and the Anti-Egfr Antibody Cetuximab Plus Radiotherapy in a CML Patient With Multiple Squamous Neoplasias

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2009English

Predicting Efficacy and Toxicity in the Era of Targeted Therapy: Focus on Anti-Egfr and Anti-Vegf Molecules

Current Drug Metabolism
Clinical BiochemistryPharmacology
2011English

When Two Is Better Than One

BioTechniques
BiochemistryBiotechnologyGeneticsMolecular Biology
2016English

Skin Toxicity Ant Anti-Egfr-Therapy: A Mock Trouble for Elderly and Frail Patients With McRc

Annals of Hematology & Oncology
2018English

A Novel Form of 4-1bbl Has Better Immunomodulatory Activity Than an Agonistic Anti-4-1bb Ab Without Ab-Associated Severe Toxicity

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy